1. Home
  2. BBNX vs CCD Comparison

BBNX vs CCD Comparison

Compare BBNX & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • CCD
  • Stock Information
  • Founded
  • BBNX 2015
  • CCD 2014
  • Country
  • BBNX United States
  • CCD United States
  • Employees
  • BBNX N/A
  • CCD N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • CCD Trusts Except Educational Religious and Charitable
  • Sector
  • BBNX Health Care
  • CCD Finance
  • Exchange
  • BBNX Nasdaq
  • CCD Nasdaq
  • Market Cap
  • BBNX 649.9M
  • CCD 533.8M
  • IPO Year
  • BBNX 2025
  • CCD N/A
  • Fundamental
  • Price
  • BBNX $12.67
  • CCD $20.47
  • Analyst Decision
  • BBNX Strong Buy
  • CCD
  • Analyst Count
  • BBNX 10
  • CCD 0
  • Target Price
  • BBNX $25.20
  • CCD N/A
  • AVG Volume (30 Days)
  • BBNX 467.2K
  • CCD 96.1K
  • Earning Date
  • BBNX 07-29-2025
  • CCD 01-01-0001
  • Dividend Yield
  • BBNX N/A
  • CCD 10.61%
  • EPS Growth
  • BBNX N/A
  • CCD N/A
  • EPS
  • BBNX N/A
  • CCD N/A
  • Revenue
  • BBNX $69,830,000.00
  • CCD N/A
  • Revenue This Year
  • BBNX $32.79
  • CCD N/A
  • Revenue Next Year
  • BBNX $36.59
  • CCD N/A
  • P/E Ratio
  • BBNX N/A
  • CCD N/A
  • Revenue Growth
  • BBNX 38911.17
  • CCD N/A
  • 52 Week Low
  • BBNX $8.89
  • CCD $16.93
  • 52 Week High
  • BBNX $24.50
  • CCD $24.68
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • CCD 56.70
  • Support Level
  • BBNX N/A
  • CCD $20.27
  • Resistance Level
  • BBNX N/A
  • CCD $20.60
  • Average True Range (ATR)
  • BBNX 0.00
  • CCD 0.18
  • MACD
  • BBNX 0.00
  • CCD 0.13
  • Stochastic Oscillator
  • BBNX 0.00
  • CCD 91.64

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About CCD Calamos Dynamic Convertible & Income Fund

Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.

Share on Social Networks: